rss
J Clin Pathol 2007;60:1384-1391 doi:10.1136/jcp.2006.044891
  • Viruses and lymphomas

A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease

  1. P Riley1,
  2. J O’Donohue1,
  3. M Crook2
  1. 1
    Department of Gastroenterology, University Hospital Lewisham, London, UK
  2. 2
    Department of Biochemistry, University Hospital Lewisham, London, UK
  1. Mr P Riley, Department of Gastroenterology, University Hospital Lewisham, Lewisham High Street, London SE13 6LH, UK; paul.riley{at}kcl.ac.uk
  • Accepted 10 April 2007
  • Published Online First 4 May 2007

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder in western countries, and its incidence is increasing. This review outlines the significant health burden posed by NAFLD and discusses what is presently known about its pathogenesis, including the roles of the metabolic syndrome, obesity, insulin resistance, hepatic steatosis, reactive oxygen species, inflammatory cytokines and adipocytokines. The way in which NAFLD is clinically diagnosed is described, and areas of uncertainty surrounding its investigation are identified, before discussing the relative merits of the limited treatment options available and looking ahead to potential therapeutic strategies for the future.

Footnotes

  • Competing interests: None.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.